EXTREMELY SEVERE COURSE OF A NEW CORONAVIRUS INFECTION IN A PREGNANT WOMAN
Main Article Content
Abstract
Vulvar cancer (RV) is a malignant neoplasm arising from the integumentary flat epithelium of a woman's external genitalia. In the etiology and pathogenesis of RV, 2 factors play a leading role: age-related involutive-atrophic processes of the external genitalia and infection with human papillomavirus (HPV).
In 90 % of cases, squamous cell carcinoma is morphologically verified – a malignant neoplasm arising from the integumentary flat epithelium of the external genitalia of a woman. RV accounts for 1 % of all cancer cases in women.
In the structure of the incidence of malignant neoplasms of the female genital organs, the share of primary RV is about 2-5 %. In 2018, the incidence of RV in Russia was 2.6 cases per 100 thousand women, which in absolute numbers amounted to 2060 cases.
A clinical case of vulvar cancer is presented.
Downloads
Article Details
Section
References
Oonk MHM, Planchamp F, Baldwin P, Bidzinski M, Brännström M, Landoni F, et al. European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer. Int J Gynecol Cancer. 2017; 27(4): 832-837. DOI: 10.1097/IGC.0000000000000975
Kurman RJ, Carcangiu ML, Herrington CS, Young RH, editors. WHO classification of tumours of female reproductive organs. IARC: Lyon; 2014
Zlokachestvennye novoobrazovaniya v Rossii v 2017 godu (zabolevaemost' i smertnost' /ed. Kaprina AD, Starinskogo VV, Petrovoĭ GV,). M.: 2018. 250 p. Russian (Злокачественные новообразования в России в 2017 году (заболеваемость и смертность) /под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М., 2018. 250 с.)
Hijazi Y, Gondal U, Aziz O. A systematic review of prehabilitation programs in abdominal cancer surgery. Int J Surg. 2017; 39: 156-162. DOI: 10.1016/j.ijsu.2017.01.111
Nelson G, Bakkum-Gamez J, Kalogera E, Glaser G, Altman A, Meyer LA, et al. Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update. Int J Gynecol Cancer. 2019; 29(4): 651-668. DOI: 10.1136/ijgc-2019-000356
de Almeida EPM, de Almeida JP, Landoni G, Galas FRBG, Fukushima JT, Fominskiy E, et al. Early mobilization programme improves functional capacity after major abdominal cancer surgery: a randomized controlled trial. Br J Anaesth. 2017; 119(5): 900-907. DOI: 10.1093/bja/aex250
Yelgina SI, Zakharov IS, Rudaeva EV. Women's reproductive health and features of eating behavior. Fundamental and Clinical Medicine. 2019; 4(3): 48-53. Russia (Елгина С.И., Захаров И.С., Рудаева Е.В. Репродуктивное здоровье женщин и особенности пищевого поведения //Фундаментальная и клиническая медицина. 2019. Т. 4, № 3. С. 48-53.) DOI: 10.23946/2500-0764-2019-4-3-48-53
Ben-Arye E, Samuels N, Lavie O. Integrative Medicine for Female Patients with Gynecologic Cancer. J Altern Complement Med. 2018; 24(9-10): 881-889. DOI: 10.1089/acm.2018.0163
Biglia N, Zanfagnin V, Daniele A, Robba E, Bounous VE. Lower Body Lymphedema in Patients with Gynecologic Cancer. Anticancer Res. 2017; 37(8): 4005-4015. DOI: 10.21873/anticanres.11785
Oonk MHM, Planchamp F, Baldwin P, Bidzinski M, Brännström M, Landoni F, et al. European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer. Int J Gynecol Cancer. 2017; 27(4): 832-837. DOI: 10.1097/IGC.0000000000000975
Shields LBE, Gordinier ME. Pembrolizumab in Recurrent Squamous Cell Carcinoma of the Vulva: Case Report and Review of the Literature. Gynecol Obstet Invest. 2019; 84(1): 94-98. DOI: 10.1159/000491090
Peri M, Grassadonia A, Iezzi L, Vici P, De Tursi M, Natoli C, et al. A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression. Case Rep Oncol Med. 2019; 2019: 1018492. DOI: 10.1155/2019/1018492
Borman Р. Lymphedema diagnosis, treatment, and follow-up from the view point of physical medicine and rehabilitation specialists. Turk J Phys Med Rehab. 2018; 64(3): 179-197
Shimizu A, Sawada K, Shiomi M, Kawano M, Matsumoto Y, Takiuchi T, et al. Direct oral anticoagulants are effective and safe for the treatment of venous thromboembolism associated with gynecological cancers. Int J Gynaecol Obstet. 2019; 147(2): 252-257. DOI: 10.1002/ijgo.12944
Lepori S, Fontanella C, Maltese G, Tripodi E, Martinelli F, Bogani G, et al. Phase II study of the safety and efficacy of oral capecitabine in patients with platinum-pretreated advanced or recurrent cervical carcinoma. Annals of Oncology. 2017; 28(6). DOI: https://doi.org/10.1093/annonc/mdx429.001